Graybill Bartz & Assoc LTD Abbott Laboratories Transaction History

Graybill Bartz & Assoc LTD

$271 Million
Q1 2025

A detailed history of Graybill Bartz & Assoc LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Graybill Bartz & Assoc LTD holds 53,262 shares of ABT stock, worth $7.16 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares

53,262

Previous 49,659 7.26%

Holding current value

$7.16 Million

Previous $5.66 Million 24.8%

% of portfolio

2.61%

Previous 2.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	BUY	$111.1 - $140.22 $400,293 - $505,212	3,603 Added 7.26%	53,262 $7.07 Million
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $137,195 - $161,956	1,371 Added 2.84%	49,659 $5.66 Million
Q2 2024 Jul 22, 2024	BUY	$100.73 - $112.44 $178,493 - $199,243	1,772 Added 3.81%	48,288 $5.02 Million
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $52,241 - $57,697	477 Added 1.04%	46,516 $5.29 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $19,030 - $23,294	211 Added 0.46%	46,039 $5.07 Million
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $2,483 - $2,980	-26 Reduced 0.06%	45,828 $4.44 Million
Q2 2023 Jul 21, 2023	BUY	$100.78 - $112.29 $19,148 - $21,335	190 Added 0.42%	45,854 $5 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $111,970 - $131,795	1,156 Added 2.6%	45,664 $4.62 Million
Q4 2022 Jan 23, 2023	BUY	$95.06 - $111.52 $55,324 - $64,904	582 Added 1.32%	44,508 $0
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $68,893 - $79,765	712 Added 1.65%	43,926 $4.25 Million
Q2 2022 Jul 29, 2022	SELL	$102.07 - $123.37 $126,362 - $152,732	-1,238 Reduced 2.79%	43,214 $4.7 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $896,539 - $1.09 Million	-7,863 Reduced 15.03%	44,452 $5.26 Million
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $56,032 - $68,608	485 Added 0.94%	52,315 $7.36 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $62,763 - $69,434	-538 Reduced 1.03%	51,830 $6.12 Million
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $132,025 - $155,413	1,248 Added 2.44%	52,368 $6.07 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $174,905 - $206,065	-1,607 Reduced 3.05%	51,120 $6.13 Million
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $29,820 - $32,495	-284 Reduced 0.54%	52,727 $5.77 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $13,012 - $15,803	-142 Reduced 0.27%	53,011 $5.77 Million
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $62,021 - $79,380	-810 Reduced 1.5%	53,153 $4.86 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $42,215 - $61,729	-672 Reduced 1.23%	53,963 $4.26 Million
Q4 2019 Jan 24, 2020	SELL	$78.51 - $87.4 $38,155 - $42,476	-486 Reduced 0.88%	54,635 $4.75 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $106,801 - $115,805	-1,305 Reduced 2.31%	55,121 $4.61 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $3,425 - $3,995	47 Added 0.08%	56,426 $4.75 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $49,002 - $59,244	-740 Reduced 1.3%	56,379 $4.51 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $152,099 - $172,306	2,320 Added 4.23%	57,119 $4.13 Million
Q3 2018 Oct 12, 2018	SELL	$60.81 - $73.36 $16,418 - $19,807	-270 Reduced 0.49%	54,799 $4.02 Million
Q2 2018 Jul 23, 2018	SELL	$57.57 - $63.54 $110,822 - $122,314	-1,925 Reduced 3.38%	55,069 $3.36 Million
Q1 2018 Apr 18, 2018	SELL	$56.27 - $63.62 $388,713 - $439,486	-6,908 Reduced 10.81%	56,994 $3.42 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $565,840 - $605,791	-10,541 Reduced 14.16%	63,902 $3.65 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $3.58 Million - $3.99 Million	74,443	74,443 $3.97 Million

Others Institutions Holding ABT

# of Institutions

3,546

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $235B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graybill Bartz & Assoc LTD, based on Form 13F filings with the SEC.

News

Stay updated on Graybill Bartz & Assoc LTD with notifications on news.

Account

Graybill Bartz & Assoc LTD Abbott Laboratories Transaction History